Inclusion Criteria (Arm):
- Mobile males or females, age 18 years or older
- Unilateral arm lymphoedema of secondary origin
- Pitting arm lymphoedema diagnosed as stage II or late stage II according to the International Society of Lymphology staging
- Patients who require intense bandaging therapy (approx. >= 15% increase in arm volume over the opposite healthy arm)
- Completion of all primary and adjuvant cancer treatments (surgery, chemotherapy, radiotherapy) at least 6 months prior to randomisation
- Willing to give written informed consent and willing to comply with the study protocol
Inclusion Criteria (Leg):
- Mobile males or females, age 18 years or older
- Unilateral or bilateral leg lymphoedema of primary or secondary origin
- Pitting leg lymphoedema diagnosed as stage II or late stage II according to the International Society of Lymphology staging
- Patients who require intense bandaging therapy
- Completion of all primary and adjuvant cancer treatments (surgery, chemotherapy, radiotherapy) at least 6 months prior to randomisation
- Willing to give written informed consent and willing to comply with the study protocol
Exclusion Criteria (Arm):
- Known pregnancy
- Evidence of active cancer, either local or metastatic
- A period of intense daily bandaging within the last month
- Decompensated heart failure or clinically relevant kidney or liver disease
- Known relevant arterial disease of the arms
- Deep vein thrombosis or phlebitis in the last 3 months
- Paralysis of the arms
- Clinical infection of the arms (e.g. erysipelas)
- Wounds located at the study arm that require dressing change more than once a week
- History of allergic reactions to study material
- Participation in any prospective clinical study that can potentially interfere with this study
- Participants who are, in the opinion of the clinical investigator, unsuitable for enrolment in this study, for reasons not specified in the exclusion criteria.
Exclusion Criteria (Leg):
- Known pregnancy
- Evidence of active cancer, either local or metastatic
- A period of intense daily bandaging within the last month
- Decompensated heart failure or clinically relevant kidney or liver disease
- Deep vein thrombosis or phlebitis in the last 3 months
- Known relevant arterial disease of the legs
- Paralysis of the legs
- Clinical infection of the legs (e.g. erysipelas)
- Circumferential Lymphorrhoea
- Wounds located at the study leg that require dressing change more than once a week
- History of allergic reactions to study material
- Participation in any prospective clinical study that can potentially interfere with this study
- Participants who are, in the opinion of the clinical investigator, unsuitable for enrolment in this study, for reasons not specified in the exclusion criteria.